Indegene’s wholly owned subsidiary -- Indegene Ireland has signed a Share Purchase Agreement (SPA) to acquire 100% equity shares in Warn and Co. The objective of acquisition is to further augment Indegene's capabilities and offerings in life sciences consulting business.
Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products.
